The rate of inflation rose in October and moved further away from the Federal Reserve’s 2% goal, confirming a recent uptick ...
Large-cap U.S. stocks have outperformed virtually all comers over the past 15 years. According to some of the world’s largest ...
President-elect Trump and his allies in Congress are hoping to enact massive tax cuts that could cost nearly $8 trillion over ...
Investors are buying up crash protection for their portfolios even as a sizzling postelection rally shows few signs of ...
President-elect Donald Trump has assembled what might be called a team of rivals on economic policy. But investors should ...
Oil futures finished on a mixed note, with U.S. and global benchmark prices little changed Wednesday as traders turned their ...
Several of President-elect Donald Trump ‘s Cabinet picks and appointees have been targeted by bomb threats and “swatting ...
Trump’s threatened tariffs on Canada and Mexico may boost inflation in the U.S., but there’s still “huge uncertainty” around ...
Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...
Applied Therapeutics said it has received a complete response letter from the Food and Drug Administration related to its new drug application for govorestat due to deficiencies in the clinical ...
Years ago, I was married to a doctor for 12 years. Clearly, he’s made much more than I have over our lifetimes. I’m 72 and he ...
It isn’t all bad news, said John Krinsky, chief market technician at BTIG, in a Wednesday client note. Tech’s XLK -1.62% 1.5% ...